Literature DB >> 8503909

Molecular cloning and functional expression of the human gallbladder cholecystokinin A receptor.

C D Ulrich1, I Ferber, E Holicky, E Hadac, G Buell, L J Miller.   

Abstract

Through binding to cholecystokinin (CCK) A receptors, CCK is an important physiologic regulator of both gallbladder contraction and pancreatic enzyme secretion. In this work, we have used a combination of hybridization screening of a cDNA library and polymerase chain reaction to clone a 2.1 kb cDNA which encodes the human gallbladder CCKA receptor. Nucleotide sequence analysis revealed an open reading frame encoding a 428 amino acid protein, with seven putative transmembrane domains and a high degree of homology with the rat CCKA receptor. COS cells transfected with this cDNA clone bound CCK-8 and L-364,718 with high affinities appropriate for the CCKA receptor, and exhibited a transient increase in intracellular calcium in response to CCK. This should provide an important resource for the analysis of the role of this receptor in human physiology and pathophysiology.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8503909     DOI: 10.1006/bbrc.1993.1610

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  A major predisposition locus for severe obesity, at 4p15-p14.

Authors:  Steven Stone; Victor Abkevich; Steven C Hunt; Alexander Gutin; Deanna L Russell; Chris D Neff; Robyn Riley; Georges C Frech; Charles H Hensel; Srikanth Jammulapati; Jennifer Potter; David Sexton; Thanh Tran; Drew Gibbs; Diana Iliev; Richard Gress; Brian Bloomquist; John Amatruda; Peter M M Rae; Ted D Adams; Mark H Skolnick; Donna Shattuck
Journal:  Am J Hum Genet       Date:  2002-04-15       Impact factor: 11.025

2.  Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.

Authors:  V Gigoux; B Maigret; C Escrieut; S Silvente-Poirot; M Bouisson; J A Fehrentz; L Moroder; D Gully; J Martinez; N Vaysse; A D Fourmy
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

3.  Molecular cloning, expression and pharmacological characterization of the canine cholecystokinin 1 receptor.

Authors:  Magda Francesca Morton; Jayashree Pyati; Heng Dai; Lina Li; Veronica Moreno; Nigel Paul Shankley
Journal:  Br J Pharmacol       Date:  2005-06       Impact factor: 8.739

4.  Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function.

Authors:  Kaleeckal G Harikumar; Maoqing Dong; Zhijie Cheng; Delia I Pinon; Terry P Lybrand; Laurence J Miller
Journal:  Biochemistry       Date:  2006-12-12       Impact factor: 3.162

5.  Novel benzodiazepine photoaffinity probe stereoselectively labels a site deep within the membrane-spanning domain of the cholecystokinin receptor.

Authors:  Elizabeth M Hadac; Eric S Dawson; James W Darrow; Elizabeth E Sugg; Terry P Lybrand; Laurence J Miller
Journal:  J Med Chem       Date:  2006-02-09       Impact factor: 7.446

Review 6.  Cholecystokinin receptors.

Authors:  P Boden; M D Hall; J Hughes
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

7.  Expression pattern and action analysis of genes associated with the responses to chemical stimuli during rat liver regeneration.

Authors:  Shao-Wei Qin; Li-Feng Zhao; Xiao-Guang Chen; Cun-Shuan Xu
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

8.  Functional compensation between cholecystokinin-1 and -2 receptors in murine paraventricular nucleus neurons.

Authors:  Shahid Mohammad; Tomoya Ozaki; Kouhei Takeuchi; Katsuya Unno; Kurumi Yamoto; Eri Morioka; Soichi Takiguchi; Masayuki Ikeda
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

9.  Localization of the murine cholecystokinin A and B receptor genes.

Authors:  L C Samuelson; M S Isakoff; K A Lacourse
Journal:  Mamm Genome       Date:  1995-04       Impact factor: 2.957

10.  Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy.

Authors:  J Shlik; E Vasar; J Bradwejn
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.